_edited.png)
About Us
Who we are
Caren Pharma is a pharmaceutical company developing hormone-based therapeutics for age-related diseases. We optimize proven therapies to create next-generation treatments with a more efficient path to market. Our lead asset is a novel reformulation of two FDA-approved generics, repurposed to slow the progression of Alzheimer's disease.
6M+
Americans living with Alzheimer's
(1)
58M+
Americans aged 65+,
95% having a chronic condition
(2)
2x
Alzheimer's cases to double by 2050
(1)
95%
of hormones lost postmenopause
(3)(4)(5)
#1
Age is the greatest risk factor for neurodegenerative diseases
(1)
26%
Increased risk of Alzheimer's for every 10-unit decrease in Free Testosterone Index
(6)
1. Alzheimer's Association. 2024 Alzheimer's Disease Facts and Figures. Chicago, IL: Alzheimer's Association; 2024. Link.​
2. National Council on Aging. Get the facts on healthy aging. National Council on Aging; 2024. Link.​
3. Sivapatham S, Kumar R, Bharti S, Gupta S. Endocrine changes in postmenopausal women: A comprehensive view. J Midlife Health; 2024. Link.​
4. Gandhi J, Chen A, Dagur G, et al. The role of sex hormones in the aging female: A comprehensive review. J Mid-Life Health; 2019. Link.​
5. Australasian Menopause Society. Testosterone and Women. Published September 2020. Link.​
6. Moffat SD, Zonderman AB, Metter EJ, Kawas C, Blackman MR, Harman SM, Resnick SM. Free testosterone and risk for Alzheimer disease in older men. Neurology; 2004. Link.​
Our Team
.png)
Supported by a broad network of advisors, clinicians, professors, and industry professionals
who share our vision and provide strategic guidance
Strategic Partners
